2025-08-25T10:24:03-04:00 2024-12-31 883546340 G2 Management LLC 2985 S Walden Way Aurora CO 80013 990EZ 2024-01-01 863126815 Building the Cure Foundation Inc % Desiree Freris BUIL 7205386836 9485 LONGSTONE DR Parker CO 801347562 Desiree Freris President 2025-08-26 true Alexander Giguere P01947272 7205386836 2025-08-26 2024 2025-03-06 01:10:19Z X X https: www.buildingthecure.org X X 119065 X 35153 0 83912 65314 18598 0 53751 4815 836 8299 13950 39801 17832 -2825 54808 X 15007 9808 2825 45000 17832 54808 17832 54808 Education related to congenital heart disease During 2024 BTCF executed a $45,000 Simple Agreement for Future Equity SAFE with Organamet Bio a research entity conducting studies related to congenital heart disease. The investment is intended as a program-related investment PRI to advance BTCFs charitable purpose of supporting research into novel treatments for HLHS. The amount is reported as an asset in Part II Line 24 and not as a grant expense in Part I. No returns have been realized to date. The program-related investment is made in accordance with 26 CFR Section 53.4944-3. The Board of Directors has formally ratified and approved the investment as a PRI. The primary purpose of this investment is to advance the Foundations charitable mission of supporting congenital heart disease research. Any potential return on investment is incidental to this charitable purpose. 0 0 Desiree Freris President and Founder 15 0 0 0 Terry Kraiser Treasurer 5 0 0 0 Angela Gonzales Board Member 2 0 0 0 Matuya Brand Board Member 2 0 0 0 Mary Anderson Board Member 2 0 0 0 Susanne Haugebak Board Member 2 0 0 0 Laura Lyman Board Member 2 0 0 0 false false false false false 0 false false false false CO G2 Management LLC 2985 S Walden Way Aurora CO 80013 7205386836 false false false false false false false false false false false NONE NONE true X 0 0 0 17716 35153 52869 0 0 0 106573 83912 190485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 124289 119065 243354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 243354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 124289 119065 243354 X 2024 Cure Gala 119065 35153 83912 0 0 5478 28751 2172 28913 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 119065 35153 83912 0 0 5478 28751 2172 28913 65314 18598 Part IV | PartandLinenumber:,Explanation:| Part II Line 2,CONTRIBUTION PORTION OF EVENT PROCEEDS INCLUDE DIRECT CONTRIBUTIONS MADE IN CONJUNCTION WITH THE EVENT AS WELL AS THE TICKET PURCHASE LESS THE FAIR VALUE OF GOODS AND SERVICES RECEIVED.| Part I, line 16 | Other Expenses:, Amount:| 66310 Bank Service Charges, $3873| 63010 Advertising Non-Events, $3290| 64310 Meals Non-Events, $828| 65015 Dues And Subscriptions, $308| Part I, line 20 | Explanation:, Amount:| INCORRECT CLASSIFICATION TO ASSETS IN PRIOR YEARS, $-2825| Part II, line 24 | Explanation:, BOYAmount:, EOYAmount:| Asset from prior year reclassified to net assets; represented initial contribution to organization by Founder in prior years., $2825, $0| Represents program-related investment under a Simple Agreement for Future Equity SAFE with Organamet Bio which is conducting research into development of a bio-engineered heart scaffold for transplant in patients with HLHS or heart failure., $0, $45000|